-
Orbit Genomics At BIO International Convention
Orbit Genomics CEO & Co-Founder Dede Willis was invited to speak at the BIO International Convention as a panelist for Patents in the Crosshairs: Confronting a Coordinated Assault on Intellectual Property. The panel brought together leaders from the Biotechnology Innovation Organization (BIO), Genentech, Capitol Street, and the Council for Innovation Promotion to discuss the critical
-
Orbit Genomics Wins Startup Prize Focus on Health (Non-FDA Track)
Orbit Genomics today announced that it is the grand prize winner of the Startup Prize Focus on Health 2025 in the Non-FDA track, a nationally recognized competition spotlighting transformative innovation in healthcare and life sciences. Selected from a record-breaking pool of 75 startups across 23 states, Orbit Genomics was recognized for its patented OrbiSeq™ platform,
-
Orbit Genomics Appoints Accomplished Laboratory Director Angie Purvis to Broaden Diagnostic Expertise
Orbit Genomics, a pioneer in redefining precision medicine, today announced the appointment of Angie Purvis as Laboratory Director. With over 15 years of leadership in high-complexity molecular, immunological, and clinical chemistry laboratories, Purvis brings deep expertise in laboratory-developed tests (LDTs), regulatory compliance, and diagnostic innovation to the Orbit team. “Angie’s track record in building high-quality,